Skip to the page

Data / Drug companies / Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc.: 303 products in the FDA NDC directory, labeler code 68382

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Zydus Pharmaceuticals USA Inc. (labeler code 68382) lists 303 products in the FDA National Drug Code Directory, covering 97 finished drugs by generic name. By type: 303 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on May 21, 2026.

The request: Watch Zydus Pharmaceuticals USA Inc. (FDA labeler code 68382): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68382
Products in commercial distribution
303
Packages
1,174
Finished drugs by generic name
97
Prescription products
303
Over the counter products
0
Flagged as original packager
296 of 296 products that carry the flag
Started marketing in the last 12 months
5
Products with a marketing end date set
2
Earliest marketing start
October 8, 2005
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)303100%

Products by type

TypeProductsShare
Prescription drugs303100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lamotrigine1451
Minocycline hydrochloride1129
Diltiazem hydrochloride1155
Topiramate1156
Estradiol753
Gabapentin791
Nifedipine638
Trazodone hydrochloride639
Haloperidol632
Risperidone643
Lurasidone hydrochloride528
Buspirone hydrochloride550
Doxycycline563
Venlafaxine533
Azathioprine419
Paroxetine433
Memantine hydrochloride436
Carvedilol435
Perphenazine418
Metoprolol succinate446
Tadalafil454
Methylprednisolone431
Doxazosin428
Acyclovir470
Ramipril419
Esomeprazole magnesium477
Potassium chloride484
Atenolol336
Promethazine hydrochloride349
Amlodipine besylate349
Omeprazole3106
Mesalamine341
Propafenone hydrochloride315
Oxcarbazepine346
Metformin hydrochloride379
Glyburide317
Losartan potassium343
Oxybutynin36
Etodolac331
Amiodarone hydrochloride335
Verapamil hydrochloride346
Labetalol hydrochloride343
Telmisartan329
Bumetanide342
Potassium citrate317
Liothyronine sodium319
Nadolol317
Glipizide and metformin hydrochloride36
Dipyridamole38
Pitavastatin calcium310
Spironolactone345
Triamterene and hydrochlorothiazide327
Venlafaxine hydrochloride348
Sirolimus322
Erlotinib35
Carbamazepine352
Midodrine hydrochloride334
Glyburide and metformin hydrochloride39
Nateglinide29
Meloxicam254
Roflumilast217
Bupropion23
Cholestyramine214
Nitrofurantoin macrocrystals220
Lansoprazole258
Fesoterodine fumarate212
Zolmitriptan222
Eletriptan hydrobromide211
Chlorthalidone242
Entecavir215
Benzonatate242
Bosentan27
Amantadine hydrochloride132
Methotrexate131
Arsenic trioxide121
Anastrozole122
Nystatin140
Pyridostigmine bromide120
Hydroxychloroquine sulfate133
Atomoxetine119
Fingolimod118
Colesevelam12
Sevelamer carbonate135
Dutasteride and tamsulosin hydrochloride14
Ezetimibe126
Sodium phenylacetate and sodium benzoate17
Famotidine1138
Budesonide140
Benztropine mesylate122
Exemestane112
Bromocriptine mesylate19
Diflunisal16
Divalproex sodium148
Tamsulosin hydrochloride138
Gemfibrozil129
Clobetasol propionate140
Acamprosate calcium110

Dosage forms

Dosage formProductsShare
Tablet11036.3%
Tablet, film coated5417.8%
Tablet, extended release3411.2%
Capsule, extended release289.2%
Capsule196.3%
Tablet, coated82.6%
Tablet, film coated, extended release82.6%
Patch72.3%
Capsule, delayed release51.7%
Capsule, coated pellets51.7%
Tablet, orally disintegrating41.3%
Tablet, delayed release31%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Verapamil hydrochloride68382-563TabletGeneric drugs (ANDA)May 21, 2026
Verapamil hydrochloride68382-562TabletGeneric drugs (ANDA)May 21, 2026
Verapamil hydrochloride68382-561TabletGeneric drugs (ANDA)May 21, 2026
Trazodone Hydrochloride68382-610TabletGeneric drugs (ANDA)January 22, 2026
Trazodone Hydrochloride68382-609TabletGeneric drugs (ANDA)January 22, 2026
Gabapentin68382-357TabletGeneric drugs (ANDA)September 18, 2025
Gabapentin68382-356TabletGeneric drugs (ANDA)September 18, 2025
Gabapentin68382-355TabletGeneric drugs (ANDA)September 18, 2025
Oxcarbazepine68382-693TabletGeneric drugs (ANDA)July 10, 2025
Oxcarbazepine68382-692TabletGeneric drugs (ANDA)July 10, 2025
Oxcarbazepine68382-691TabletGeneric drugs (ANDA)July 10, 2025
Minocycline hydrochloride68382-550Tablet, extended releaseGeneric drugs (ANDA)June 12, 2025
Minocycline hydrochloride68382-534Tablet, extended releaseGeneric drugs (ANDA)June 12, 2025
Minocycline hydrochloride68382-532Tablet, extended releaseGeneric drugs (ANDA)June 12, 2025
Topiramate68382-498Capsule, coated pelletsGeneric drugs (ANDA)October 24, 2024
Topiramate68382-864Capsule, extended releaseGeneric drugs (ANDA)September 10, 2024
Topiramate68382-863Capsule, extended releaseGeneric drugs (ANDA)September 10, 2024
Topiramate68382-769Capsule, extended releaseGeneric drugs (ANDA)September 10, 2024
Gabapentin68382-608TabletGeneric drugs (ANDA)January 25, 2024
Gabapentin68382-607TabletGeneric drugs (ANDA)January 25, 2024
Topiramate68382-358Capsule, extended releaseGeneric drugs (ANDA)November 13, 2023
Pitavastatin calcium68382-483TabletGeneric drugs (ANDA)November 2, 2023
Pitavastatin calcium68382-482TabletGeneric drugs (ANDA)November 2, 2023
Pitavastatin calcium68382-481TabletGeneric drugs (ANDA)November 2, 2023
Estradiol68382-329PatchGeneric drugs (ANDA)November 2, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.